# Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)

> **NCT05306028** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Pancretic Cancer
- Diabete Mellitus

## Interventions

- **DRUG:** Metformin or insulin treatment

## Key facts

- **NCT ID:** NCT05306028
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05306028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05306028, "Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05306028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*